Literature DB >> 3569696

The effect of sulphonylurea on the in vivo tissue uptake of glucose in normal rats.

A D Mooradian.   

Abstract

To evaluate the effect of sulphonylurea on in vivo tissue uptake of glucose, the arterial injection tissue-sampling technique of Oldendorf was used to measure the glucose uptake of brain; liver; subcutaneous fat; and of three skeletal muscles, the masseter, femoris and soleus. Rats gavaged with glipizide 5 mg/kg daily for 5 days were compared to vehicle-treated rats. The serum glucose levels at the time of the experiment were identical in the two groups (10.36 +/- 0.42 mmol/l vs 10.38 +/- 0.36 mmol/l). Glipizide treatment did not result in an increase in glucose uptake by the various tissues studied. It is concluded that, under physiological conditions in non-fasted rats, sulphonylureas do not significantly alter tissue uptake of glucose.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3569696     DOI: 10.1007/bf00274583

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

1.  Comparison of plasma insulin levels following administration of tolbutamide and glucose.

Authors:  R S YALOW; H BLACK; M VILLAZON; S A BERSON
Journal:  Diabetes       Date:  1960 Sep-Oct       Impact factor: 9.461

2.  Clinical and experimental studies of insulin secretion following tolbutamide and metahexamide administration.

Authors:  E F PFEIFFER; M PFEIFFER; H DITSCHUNEIT; C S AHN
Journal:  Ann N Y Acad Sci       Date:  1959-09-25       Impact factor: 5.691

3.  The effects of sulfonylureas on peripheral metabolic processes.

Authors:  G S Levey
Journal:  Fed Proc       Date:  1977-12

4.  Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard.

Authors:  W H Oldendorf
Journal:  Brain Res       Date:  1970-12-01       Impact factor: 3.252

5.  Sulphonylureas increase the number of insulin receptors.

Authors:  M N Feinglos; H E Lebovitz
Journal:  Nature       Date:  1978-11-09       Impact factor: 49.962

6.  Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels.

Authors:  W C Duckworth; S S Solomon; A E Kitabchi
Journal:  J Clin Endocrinol Metab       Date:  1972-10       Impact factor: 5.958

7.  Insulin binding and glucose uptake differences in rodent skeletal muscles.

Authors:  A Bonen; M H Tan; W M Watson-Wright
Journal:  Diabetes       Date:  1981-08       Impact factor: 9.461

8.  Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus.

Authors:  M S Greenfield; L Doberne; M Rosenthal; B Schulz; A Widstrom; G M Reaven
Journal:  Diabetes       Date:  1982-04       Impact factor: 9.461

9.  Effects of plasma glucose concentration on glucose utilization and glucose clearance in normal man.

Authors:  C A Verdonk; R A Rizza; J E Gerich
Journal:  Diabetes       Date:  1981-06       Impact factor: 9.461

10.  Sulfonylurea potentiates insulin-induced recruitment of glucose transport carrier in rat adipocytes.

Authors:  D B Jacobs; C Y Jung
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

  10 in total
  2 in total

1.  Tolbutamide reduces the incidence of diabetes mellitus, but not insulitis, in the non-obese-diabetic mouse.

Authors:  A J Williams; P E Beales; J Krug; E Procaccini; A Signore; S Xu; E A Gale; P Pozzilli
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

Review 2.  Drug therapy of non-insulin-dependent diabetes mellitus in the elderly.

Authors:  A D Mooradian
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.